NCT04257188

Brief Summary

The aim of this prospective study is to investigate the feasibility of performing minimally invasive vitrectomy under sub-tenon anesthesia in terms of intraoperative patients' tolerance and the surgeon's confidence. In particular, the tolerance and pain sensation during the operation as well as the possible perception of light and colour sensations are to be recorded with the help of questionnaires. In addition, the surgeon's impressions regarding eye motility, chemosis and general feasibility will be evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
67

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 7, 2019

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

November 19, 2019

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 5, 2020

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2022

Completed
Last Updated

May 5, 2022

Status Verified

April 1, 2022

Enrollment Period

2.2 years

First QC Date

November 19, 2019

Last Update Submit

April 29, 2022

Conditions

Keywords

Sub-tenon AnesthesiaVitrectomySutureless vitrectomy

Outcome Measures

Primary Outcomes (3)

  • Sensation of pain

    1. 11-point numeric scale ranges from '0' (means "no pain") to '10' (means "worst pain imaginable"), Questionnaire 2. Wong-Baker FACES® Scale (6 Faces, range no hurt - hurts worst), Questionnaire

    1 Day

  • Discomfort

    11-point numeric scale ranges from '0' (means "no discomfort") to '10' (means "worst discomfort imaginable"), Questionnaire

    1 Day

  • Visual Sensations

    4 questions, Likert scale ("yes", "no", "don't know/not sure"), Questionnaire 1. perception of details during surgery (instruments, surgeon's face) 2. perception of colors during surgery 3. perception of lights or shadows 4. no light perception at all during surgery

    1 Day

Secondary Outcomes (3)

  • Chemosis

    1 Day

  • Eye movement

    1 Day

  • Surgeon's general feeling of comfort during the surgery

    1 Day

Study Arms (2)

minimally invasive vitrectomy under subtenon anaesthesia

Procedure: minimally invasive vitrectomy under subtenon anaesthesia

minimally invasive vitrectomy under general anaesthesia

Procedure: minimally invasive vitrectomy under subtenon anaesthesia

Interventions

The safety and feasibility in terms of tolerance and pain sensation during the surgery as well as the possible perception of light and colour sensations in minimally invasive vitrectomy under sub-tenon anesthesia shall be investigated.

minimally invasive vitrectomy under general anaesthesiaminimally invasive vitrectomy under subtenon anaesthesia

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study population is acquired from the patient collective of the eye clinic of the University Hospital Aachen and have a medical indication for vitrectomy, which is independent of study participation.

You may qualify if:

  • Age over 40 years
  • Presence of a clinical condition that requires surgical treatment with vitrectomy and does not necessarily require general anesthesia (retinal detachment, endophthalmitis, vitreous hemorrhage, after silicone oil surgery, vitreomacular traction, epiretinal gliosis, macular holes, subretinal bleeding, lens luxation).
  • The medical indication for vitrectomy is not linked to study participation. Not until the patient has consented to the vitrectomy (standardized information forms) potential study subjects will be approached to participate in the clinical trial.
  • Willingness to participate in the clinical trial
  • Understanding the objectives of the clinical trial and the study process
  • Signed informed consent form

You may not qualify if:

  • Concomitant diseases of the eye
  • State after filtering glaucoma operations
  • Distinct corneal opacities, which make the examination considerably more difficult
  • Complicated proliferative vitreoretinopathy
  • Lack of understanding of the study, its objectives and study conduct
  • Psychiatric diseases
  • Pregnancy
  • Simultaneous participation in another clinical trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinic for Ophthalmology, University Hospital RWTH Aachen

Aachen, 52066, Germany

Location

Related Publications (1)

  • Lohmann T, Baumgarten S, Prinz J, Walter P, Koutsonas A. Safety and feasibility of sutureless pars-plana vitrectomy in sub-Tenon anesthesia (SAFE-VISA): a prospective study. Eur J Med Res. 2023 Oct 30;28(1):472. doi: 10.1186/s40001-023-01447-2.

Study Officials

  • Antonis Koutsonas, Dr. med.

    Clinic for Ophthalmology, University Hospital RWTH Aachen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. med. Antonis Koutsonas

Study Record Dates

First Submitted

November 19, 2019

First Posted

February 5, 2020

Study Start

November 7, 2019

Primary Completion

December 31, 2021

Study Completion

March 31, 2022

Last Updated

May 5, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations